No.25 Central Pharmaceutical JSC (HSTC:UPH) ROCE % : 0.00% (As of . 20)

View and export this data going back to 2016. Start your Free Trial

What is No.25 Central Pharmaceutical JSC ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. No.25 Central Pharmaceutical JSC's annualized ROCE % for the quarter that ended in . 20 was 0.00%.

No.25 Central Pharmaceutical JSC ROCE % Historical Data

The historical data trend for No.25 Central Pharmaceutical JSC's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

No.25 Central Pharmaceutical JSC ROCE % Chart

No.25 Central Pharmaceutical JSC Annual Data

Trend

ROCE %

No.25 Central Pharmaceutical JSC Semi-Annual Data

ROCE %

No.25 Central Pharmaceutical JSC ROCE % Calculation

No.25 Central Pharmaceutical JSC's annualized ROCE % for the fiscal year that ended in . 20 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: . 20 )		(A: . 20 )		(A: . 20 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: . 20 )		(A: . 20 )		(A: . 20 )
	=		/	( ( ( - )	+	( - ) )	/ )
	=		/	( (	+	)	/ )
	=		/
	=	%

No.25 Central Pharmaceutical JSC's ROCE % of for the quarter that ended in . 20 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: . 20 )		(Q: . 20 )		(Q: . 20 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: . 20 )		(Q: . 20 )		(Q: . 20 )
	=		/	( ( ( - )	+	( - ) )	/ )
	=		/	( (	+	)	/ )
	=		/
	=	%

(1) Note: The EBIT data used here is one times the annual (. 20) EBIT data.

No.25 Central Pharmaceutical JSC (HSTC:UPH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

No.25 Central Pharmaceutical JSC ROCE % Related Terms

Thank you for viewing the detailed overview of No.25 Central Pharmaceutical JSC's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

No.25 Central Pharmaceutical JSC Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » No.25 Central Pharmaceutical JSC (HSTC:UPH) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

448B Nguyen Tat Thanh, Ward 18, District 4, Ho Chi Minh, VNM

Website

https://uphace.vn

No.25 Central Pharmaceutical JSC is engaged in the manufacturing and trading of pharmaceutical products and cosmetics. Its products comprise Rheumatin, Tribelus, Atorvastatin, and Cezirate among others.

No.25 Central Pharmaceutical JSC Headlines

No Headlines